Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse

Abstract

There is an exceptionally high incidence of central nervous system relapse in patients with diffuse large B-cell lymphoma and kidney involvement at diagnosis. The addition of rituximab may improve overall survival in this poor-risk population, likely through improved control of systemic disease.